LSL

LifeScience Logistics Enhances Offerings with Innovative Sampling & Dispensing Suite at Raleigh-Durham Facility

Retrieved on: 
Tuesday, March 5, 2024

Its new ISO Grade C cleanroom suite for pharmaceutical sampling and dispensing will support efficient quality control testing, research and development, and clinical trial efforts for LSL’s partners.

Key Points: 
  • Its new ISO Grade C cleanroom suite for pharmaceutical sampling and dispensing will support efficient quality control testing, research and development, and clinical trial efforts for LSL’s partners.
  • This state-of-the-art sampling and dispensing suite will enable Research Triangle Park-area pharmaceutical manufacturers to not only store and distribute products via LSL, but also handle their sampling and dispensing needs under one roof.
  • The addition of our Raleigh-Durham cleanroom suite is one of the many ways we continue to expand our service offerings and respond to the evolution of healthcare supply chain demands,” David Cheetham, CEO of LifeScience Logistics, stated.
  • “Sampling [in particular] is a critical step in ensuring the quality of pharmaceutical products,” Cheetham says.

120Water Secures $43M Growth Investment Led by Edison Partners

Retrieved on: 
Wednesday, January 10, 2024

Growth equity investment firm Edison Partners today announced leading a $43 million growth investment in 120Water , a leading cloud-based water management and testing system based in Zionsville, Indiana, with continued participation from Allos Ventures.

Key Points: 
  • Growth equity investment firm Edison Partners today announced leading a $43 million growth investment in 120Water , a leading cloud-based water management and testing system based in Zionsville, Indiana, with continued participation from Allos Ventures.
  • The new funds will be used to further expand the 120Water team, technology investments, and go-to-market efforts.
  • The platform’s rapid adoption is driving a sharp increase in new customers and revenue growth of more than 60% annually.
  • Since its inception in 1986, Edison has invested in more than 260 companies.

LifeScience Logistics Expands Raleigh-Durham Presence with Second Pharmaceutical Storage and Distribution Facility for Pharmaceutical and Medical Device Manufacturers

Retrieved on: 
Friday, January 5, 2024

This facility will be LSL’s 17th strategic location across the United States and the second location added to the Raleigh-Durham hub.

Key Points: 
  • This facility will be LSL’s 17th strategic location across the United States and the second location added to the Raleigh-Durham hub.
  • This innovative 249,600 SF facility, located in the heart of Research Triangle Park, will expand LSL’s capacity to provide FDA-registered, cGMP-compliant, temperature-controlled storage and end-to-end 3PL solutions to pharmaceutical and medical device manufacturers operating in the Raleigh-Durham area.
  • “We decided to build an additional facility to support the unprecedented demand for both pharmaceutical and medical device temperature-controlled storage and distribution in the Raleigh-Durham region.”
    LSL anticipates strong demand for the solutions offered in their latest Raleigh-Durham facility.
  • The new location will ensure the safe and compliant storage of finished goods, API, raw materials, and packaging materials.

Oberkotter Foundation Announces Dr. Teresa Caraway as CEO

Retrieved on: 
Friday, December 8, 2023

Dr. Caraway succeeds Bruce Rosenfield, trustee, who has served as the executive director of the Foundation for over 20 years.

Key Points: 
  • Dr. Caraway succeeds Bruce Rosenfield, trustee, who has served as the executive director of the Foundation for over 20 years.
  • She first joined the organization in 2012 as the CEO of Hearing First, an educational initiative of the Oberkotter Foundation that supports families and professionals on the LSL journey through awareness, education, and community.
  • "I am humbled and excited to take on the role of CEO at the Oberkotter Foundation.
  • "Dr. Caraway's visionary leadership makes her the ideal leader to guide the Oberkotter Foundation through its next phase of growth and impact.

Hearing First Unveils 2024 Course Catalog with New Pediatric Audiology Offerings

Retrieved on: 
Thursday, December 7, 2023

PHILADELPHIA, Dec. 7, 2023 /PRNewswire/ -- Hearing First, a subsidiary of the Oberkotter Foundation, has announced its 2024 course catalog. The catalog features new and return courses focused on pediatric audiology and Listening and Spoken Language (LSL) best practices to improve LSL outcomes for children who are deaf or hard of hearing. All courses are free to attend and learners can earn CE credits from the American Academy of Audiology (AAA), AG Bell Academy, and American Speech Language and Hearing Association (ASHA). The 2024 course catalog opened for registration earlier this week.

Key Points: 
  • PHILADELPHIA, Dec. 7, 2023 /PRNewswire/ -- Hearing First , a subsidiary of the Oberkotter Foundation , has announced its 2024 course catalog.
  • The catalog features new and return courses focused on pediatric audiology and Listening and Spoken Language (LSL) best practices to improve LSL outcomes for children who are deaf or hard of hearing.
  • Hearing First courses translate the latest research and evidence-based science for hearing healthcare industry professionals to apply to their practice.
  • In 2024, Hearing First expanded its course offerings and increased the number of pediatric-audiology focused courses to help achieve that goal."

LSL Pharma Group Announces Closing of First Tranche of Convertible Debentures Offering

Retrieved on: 
Wednesday, November 1, 2023

The net proceeds of the Offering will be used for working capital, capital expenditures, and for general corporate purposes.

Key Points: 
  • The net proceeds of the Offering will be used for working capital, capital expenditures, and for general corporate purposes.
  • The Offering was led by iA Capital Markets as sole agent and sole bookrunner (the “Agent”).
  • In connection with the first tranche of the Offering, the Company paid to the Agent a cash commission of $160,510 and issued 229,300 broker warrants (the “Broker Warrants”).
  • All securities issued pursuant to the Offering are subject to the applicable statutory hold period of four months and one day from November 1, 2023 (the “Initial Closing Date”).

Groupe LSL Pharma Announces New Orders with an Annual Revenue Potential in Excess of $2.6 Million

Retrieved on: 
Wednesday, October 25, 2023

BOUCHERVILLE, Quebec, Oct. 25, 2023 (GLOBE NEWSWIRE) -- Groupe LSL Pharma Inc. (TSXV: LSL) – (“the Company” or “LSL Pharma Group”), a Canadian integrated pharmaceutical company, announces today that its subsidiary LSL Laboratory (“LSL”) has received new orders for natural health products.

Key Points: 
  • BOUCHERVILLE, Quebec, Oct. 25, 2023 (GLOBE NEWSWIRE) -- Groupe LSL Pharma Inc. (TSXV: LSL) – (“the Company” or “LSL Pharma Group”), a Canadian integrated pharmaceutical company, announces today that its subsidiary LSL Laboratory (“LSL”) has received new orders for natural health products.
  • These new orders reflect the addition of new clients, as well as volume increases from certain existing clients.
  • In addition, LSL Pharma Group is engaged in negotiations for potential additional orders related to natural health products.
  • Should all discussions be successful, these orders could result in annual sales of approximately $1.5 million.

LSL Pharma Group Announces Exclusive Distribution Agreement With Fera Pharmaceuticals to Alleviate Drug Shortage in U.S. Hospitals

Retrieved on: 
Wednesday, October 18, 2023

BOUCHERVILLE, Québec, Oct. 18, 2023 (GLOBE NEWSWIRE) -- LSL Pharma Group Inc. (TSXV: LSL), (the “Company” or “LSL Pharma Group”), a Canadian integrated pharmaceutical company, announced today that it has entered into an exclusive agreement with Fera Pharmaceuticals, LLC (“Fera”), a U.S. specialty pharmaceutical company, to provide Erythromycin ophthalmic ointment USP (5mg/g) for the treatment of newborns in U.S. hospitals.

Key Points: 
  • BOUCHERVILLE, Québec, Oct. 18, 2023 (GLOBE NEWSWIRE) -- LSL Pharma Group Inc. (TSXV: LSL), (the “Company” or “LSL Pharma Group”), a Canadian integrated pharmaceutical company, announced today that it has entered into an exclusive agreement with Fera Pharmaceuticals, LLC (“Fera”), a U.S. specialty pharmaceutical company, to provide Erythromycin ophthalmic ointment USP (5mg/g) for the treatment of newborns in U.S. hospitals.
  • The agreement essentially focuses on fulfilling the need in the one-gram tube market.
  • Under the terms of the agreement, LSL Pharma Group, via its manufacturing subsidiary Steri-Med Pharma Inc. (“Steri-Med”), could initially supply up to 25% of the four million doses required annually in the U.S. hospital market.
  • “LSL Pharma Group is pleased to respond to this urgent healthcare need by making our eye medication readily available to the U.S. market,” stated François Roberge, President and Chief Executive Officer of LSL Pharma Group.

LifeScience Logistics’ Lakeland Facility Becomes Vital Hub for Hurricane Disaster Relief Operations in Florida

Retrieved on: 
Saturday, September 2, 2023

This week, a Lakeland, FL warehouse facility operated by LifeScience Logistics emerged as a crucial staging and dispatch center for Hurricane disaster relief efforts in Florida.

Key Points: 
  • This week, a Lakeland, FL warehouse facility operated by LifeScience Logistics emerged as a crucial staging and dispatch center for Hurricane disaster relief efforts in Florida.
  • Thomas DiBernardo, coordinator of Florida CARES (Bureau of Emergency Medical Oversight) and his team arrived at the facility on the afternoon of August 28th.
  • Each ambulance was equipped with a two-person crew and dispatched as needed to support evacuation and relief efforts.
  • LSL worked in close coordination with state emergency management teams to provide vital support and resources during this challenging time.

BlueConduit Launches a Water System-level Lead Service Line Count and Replacement Cost Estimator

Retrieved on: 
Monday, July 10, 2023

ANN ARBOR, Mich., July 10, 2023 /PRNewswire-PRWeb/ -- Water utilities nationwide are working to find and replace their lead service lines (LSLs) without knowing how many are in their system. To help utilities plan, water analytics pioneer BlueConduit launched a free LSL count and replacement cost estimator.

Key Points: 
  • An estimated 9 million lead pipes carry drinking water to millions of people in the U.S.; BlueConduit's LSL count and replacement cost estimator is available to help utilities plan.
  • To help utilities plan, water analytics pioneer BlueConduit launched a free LSL count and replacement cost estimator .
  • "Water utilities tell us they lack insight into their total lead service line count and the estimated cost to remove those lines," says Lorne Groe, CEO at BlueConduit.
  • In December 2021, the EPA released its Lead and Copper Rule Revision , which requires all U.S. water systems to develop address-level lead service line inventories by October 16, 2024.